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1. ABSTRACT 
Dementia is one of the clinical triad of idiopathic normal pressure hydrocephalus 
(iNPH). Although it is necessary to know detailed features of cognitive and behavioral 
symptoms for accurate diagnosis and appropriate treatment, systematic studies addressing 
these issues are very scarce. Previous investigations on cognitive dysfunction in iNPH 
focused on attention, executive function, and memory, and paid less attention to ‘posterior 
cortical’ functions, such as visuoperceptual and visuospatial functions. As for 
neuropsychiatric symptoms, no systematic investigations have been conducted so far 
except two observational studies. In STUDY 1, broad domains of cognitive functions were 
examined in patients with iNPH. In STUDY 2, neuropsychiatric symptoms in iNPH were 
systematically assessed by using the Neuropsychiatric Inventory (NPI). I found that 
patients with iNPH were impaired in broader cognitive domains and develop more diverse 
neuropsychiatric symptoms than previously reported. The cognitive domains affected in 
iNPH include not only executive function and memory but also 
visuoperceptual/visuospatial functions. Although negative symptoms such as apathy and 
decreased arousal have previously been emphasized, a high prevalence of positive 
symptoms such as agitation and irritability were noted. After CSF shunt surgery, a 
significant improvement was observed only in executive function, but not in 
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visuoperceptual/visuospatial functions. Among the various neuropsychiatric symptoms, 
only agitation and cognitive fluctuation were responsive to shunt surgery. The present 
studies provide useful information on detailed nature of dementia in iNPH. 
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2. INTRODUCTION 
2-1. Diagnostic concepts of idiopathic normal pressure hydrocephalus 
As the number of elderly people in Japan is increasing, the medical care of elderly 
people has been increasingly important. In particular, cognitive and movement disorders 
are serious problems because they deprive sufferers of the ability to perform independent 
social activities and have a profound effect on their quality of life. Idiopathic normal 
pressure hydrocephalus (iNPH) is a disorder causing cognitive and movement impairments 
in aged people, which has therefore recently elicited renewed attention.  
Hakim and Adams first described normal pressure hydrocephalus (NPH) in 1965.1, 2 
NPH manifests as a triad of gait disturbance, dementia, and urinary incontinence with 
ventricular dilation and normal intracranial pressure.3, 4 These symptoms can be reversed 
by cerebrospinal fluid (CSF) shunt surgery. NPH is classified into two types according to 
etiology: secondary NPH (sNPH) occurring subsequent to preceding illnesses, such as 
subarachnoid hemorrhage and meningitis; and iNPH of unknown etiology. Unlike sNPH, 
the diagnosis of iNPH is often challenging, because the specific inciting disease cannot be 
unidentified and the onset of symptoms is insidious and their progression gradual. 
Historically, this ambiguity in diagnosing iNPH produced a surge of shunt surgery in the 
period following Adams and Hakim’s first report.1, 2 As a result, surgical treatment was 
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undertaken for dementia arising from diseases other than iNPH, and failed to produce any 
beneficial results. After the era of enthusiasm for shunt surgery, many neurologists and 
neurosurgeons hesitated to give the surgical treatment to patients with suspected iNPH. 
However, recent developments in diagnostic imaging tools, e.g. computed tomography 
(CT) and magnetic resonance imaging (MRI), have enabled us to differentiate iNPH from 
other neurological diseases, and there is now a resurgence of interest in the diagnosis and 
treatment of this condition.  
Until recently, there was no consensus of agreement about the diagnostic criteria for 
iNPH. Classically, NPH is defined simply as a condition with the triad of symptoms 
described above, which are improved by CSF shunt surgery. This ‘classic’ definition does 
not provide us with any tools for preoperative differentiation from other neurological 
diseases presenting with similar symptoms. As the first step towards the establishment of 
preoperative diagnostic procedures, the Japanese Society of Normal Pressure 
Hydrocephalus (JSNPH) recently published criteria consisting of three diagnostic levels: 
possible, probable, and definite iNPH.5, 6 Possible iNPH corresponds to a condition 
involving the presence of one or more of the clinical triad, onset of symptoms during the 
sixties or older, ventricular dilation on CT and MRI, and clear CSF with normal CSF 
pressure. The diagnosis of probable iNPH is made when the patient’s condition fulfills the 
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criteria for possible iNPH with improvement of symptoms after the CSF tap test or 
continuous CSF drainage. The diagnosis of definite iNPH is determined by the 
improvement of symptoms after CSF shunt surgery. Also, the international guidelines 
were published in 20057-11, and the both two guidelines are same in proposing the practical 
solutions to establish the preoperative diagnostic procedures, although both were different 
in some points. Details of the JSNPH criteria are shown in Table 1.  
 
2-2. Clinical symptoms of iNPH 
2-2-1. Gait disturbance and urinary dysfunction 
Gait disturbance is an early and almost essential symptom, and shows the most notable 
improvement of all the triad of symptoms after CSF removal. Although gait disturbance in 
iNPH shares the features of short step, start hesitation, and increased instability on turning 
with Parkinson’s disease (PD), it can be differentiated from PD by broad base and little 
effect of external cues. The gait disturbance of iNPH is often described as ataxic/apraxic 
gait.12, 13 Improvement of gait after CSF removal is characterized by increased stride length 
and decreased number of steps on turning.12 
Urinary dysfunction in iNPH is characterized by overactive bladder symptoms, e.g., 
nocturnal pollakisuria, urinary urgency, and urge incontinence. Although incontinence 
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reportedly has the lowest prevalence of the triad of symptoms and occurs after the two 
other symptoms, overactive bladder symptoms occur in more than 90% of iNPH patients.14 
The contribution of frontal lobe dysfunction has been demonstrated in previous 
neuroimaging investigations.14-16 Sakakibara and colleagues14 suggested that frontal lobe 
dysfunction is associated with both dysfunction of the lower urinary tract per se and 
functional incontinence arising from cognitive impairment. 
 
2-2-2. Cognitive symptoms 
Previous studies of cognitive dysfunction in iNPH (and NPH in general) have focused 
on attention, executive function, and memory, whereas less attention has been paid to 
‘posterior cortical’ functions, such as visuoperceptual and visuospatial function. This 
imbalance presumably stems from the concept that NPH is one of a group of prototypic 
disorders of ‘subcortical dementia’. Subcortical dementia is a cognitive-behavioral 
syndrome arising subsequent to disruption of the frontal-subcortical circuits, and 
characterized by executive dysfunction, poor attention, cognitive slowing, and memory 
impairment with relatively preserved recognition memory. However, pathological changes 
in NPH are not restricted to the frontal regions of the cerebrum, but also affect posterior 
brain regions.16 In addition, these changes may be reversed to some extent as a result of 
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CSF shunt surgery.17, 18 It is necessary to characterize the cognitive dysfunction of iNPH in 
a more comprehensive way, and to identify which symptoms is likely to response to CSF 
shunt treatment. 
 
2-2-3. Neuropsychiatric symptoms 
Neuropsychiatric symptoms, or behavioral and psychological symptoms of dementia 
(BPSD), include non-cognitive symptoms such as apathy, depression, agitation, and 
psychosis. Neuropsychiatric symptoms give rise to serious problems in patients’ quality of 
life and great burden and distress in their caregivers. Although a number of studies have 
addressed the cognitive aspects of dementia, only a few studies have focused on the 
neuropsychiatric disturbances in iNPH, which have reported drowsiness and a lethargic 
tendency as characteristic symptoms.19, 20 There were no studies examining systematically 
and quantitatively the neuropsychiatric symptoms of iNPH patients. 
 
2-3. Objectives 
In STUDY 1, to delineate the profile of neuropsychological deficits in iNPH, various 
cognitive domains were evaluated in preoperative patients with iNPH comparing with 
those with Alzheimer’s disease (AD), and repeated after CSF shunt treatment. In STUDY 
10 
 
2, to elucidate the features of BPSD in iNPH, neuropsychiatric symptoms in iNPH were 
assessed by using the Neuropsychiatric Inventory (NPI), an established and widely used 
tool for the assessment of BPSD, comparing with AD, and delineate the changes in the 
neuropsychiatric profile after CSF shunt surgery. 
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3. STUDY 1. Cognitive profile of iNPH 
3-1. Methods 
3-1-1. Subjects 
All procedures in this study followed the clinical study guidelines of Tohoku 
University Hospital and Akita Prefectural Center of Rehabilitation and Psychiatric 
Medicine, and were approved by the Tohoku University Graduate School Medicine Ethical 
Committee. Written informed consent was obtained from all participants after they were 
fully explained the study procedure. 
 Patients with iNPH were consecutively recruited from patients who were admitted to 
the Department of Behavioral Neurology and Cognitive Neuroscience at Tohoku 
University Hospital and the Department of Rehabilitation Medicine at Akita Prefectural 
Center of Rehabilitation and Psychiatric Medicine from May 2006 to April 2009. All 
patients underwent comprehensive neurological and behavioral examination by 
neurologists, laboratory investigations, and MRI, single photon emission computed 
tomography (SPECT), and lumbar CSF tap test. Patients who fulfilled the JSNPH criteria 
for possible iNPH (see Table 1)6 and had narrowing of the high convexity/midline 
subarachnoid spaces on MRI underwent shunt surgery regardless of the result of CSF tap 
test. The subjects of the present study were those with definite iNPH according to the 
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criteria of JSNPH, i.e., those who showed ‘significant’ improvement of clinical symptoms 
following shunt surgery were documented at any point during the postoperative period (2 
weeks to 1 year) (see Table 1).6 Clinical symptoms were rated by using a validated scale 
developed specifically for iNPH, the iNPH Grading Scale (iNPHGS),21 in which each of 
the triad of symptoms is rated on a 4-point scale [from 0 (normal) to 12 (severe)]. 
‘Significant’ improvement was defined as improvement of 1 point or more postoperatively 
by relative to baseline on the total iNPHGS score.21 Patients who could not complete the 
neuropsychological tests for clinical reasons such as refusal of examination, delirium, and 
severe apathy were excluded. 
Thirty-four of the patients (16 women, 18 men) were included the STUDY 1 baseline 
part. Their mean (SD) age was 76.2 (4.6) years (range 65–84), and their mean duration of 
education was 10.2 (3.5) years. The mean (SD) iNPHGS scores before and after CSF shunt 
surgery were 2.5 (0.7) and 2.1 (0.8) (Wilcoxon test; Z = -3.260, p = 0.001) for cognitive, 
2.4 (0.7) and 1.7 (0.9) (Z = -4.070, p < 0.001) for gait, 2.0 (1.0) and 0.9 (1.0) (Z = -4.185, p 
< 0.001) for urinary score, and 6.9 (1.7) and 4.7 (1.8) (Z = -5.149, p < 0.001) for total score, 
respectively. Twenty-three patients received ventriculo-peritoneal (VP) shunt surgery and 
11 patients received lumbo-peritoneal (LP) shunt surgery. The mean (SD) interval between 
the neuropsychological tests and shunt surgery was 71.4 (43.4) days. 
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As disease controls, 34 patients with AD (20 women, 14 men) matched for age, sex, 
duration of education, and degree of cognitive dysfunction as assessed by the Mini-Mental 
State Examination (MMSE) were selected from the same pools of patients described above. 
Diagnosis was made according to the National Institute of Neurological and 
Communicative Diseases and Stroke/Alzheimer’s Disease and Related Disorders 
Association (NINCDS/ADRDA) criteria for probable AD.22 The means (SD) of age and 
years of education were 76.7 (4.9) years (range 64–87) and 9.5 (2.3) years, respectively. 
Thirty healthy elderly volunteers recruited from the community based on their age, sex, 
and duration of education [mean (SD) age 76.8 (5.8) years (range 70–91); 15 women, 15 
men; mean (SD) duration of education 10.5 (2.8) years] were included as normal controls 
(NC). There were no significant differences among the iNPH, AD, and NC groups in terms 
of age (F (2, 95) = 0.137, p = 0.870), sex (Pearson’s χ2 test, χ =1.015, p = 0.602), and 
duration of education (F (2, 95) =0.885, p = 0.416) (Table 2). 
Of the 34 patients, 23 were the subjects of the STUDY 1 longitudinal part. Mean (SD) 
duration of follow-up was 12.4 (1.0) months (range 12-15 months). The mean (SD) age of 
the patients was 75.4 (4.5) years (range 67–84), and mean duration of education was 10.0 
(3.2) years. 
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3-1-2. Neuropsychological assessments 
The following neuropsychological tests were carried out to evaluate various aspects of 
cognitive domains. 
(1) MMSE 23, 24 for general cognitive function. 
(2) Digit Span and Spatial Span tests of the Wechsler Memory Scale-Revised (WMS-R) 25, 
26 for attention.  
Summed scores of forward and backward spans were used for the analyses. 
(3) Word Fluency,27, 28 Trail Making Test-A (TMT-A),27, 29 and Frontal Assessment 
Battery (FAB) 30 for executive function. 
In the Word Fluency, 1-minute free recall of words with “Fu” “A” “Ni” for phoneme 
and of animal names for category were tested. In TMT-A, the number of seconds required 
to complete the task was measured. 
(4) Object Naming subtest of the Western Aphasia Battery (WAB)31, 32 for language. 
(5) Word Recall and Word Recognition subtests of the Alzheimer’s Disease Assessment 
Scale (ADAS)33, 34 for episodic memory. 
Episodic memory involves two distinct processes, recall and recognition. Recall is 
defined as the ability to retrieve memory contents without the use of external cue, and 
recognition is the ability to judge whether given information has been experienced before 
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or not. In the present study, Word Recall subtest of the ADAS measured the free recall 
ability, and Word Recognition subtest measured of the recognition memory. In addition, I 
used d’ for measures of general performance of recognition (true recognition and false 
recognition), which was calculated according to the formula:  
d’ = z(true recognition rate) – z(false recognition rate).35 
 (6) Visual Discrimination (Length, Size, Direction, and Complex Form), Overlapping 
Figures, and Visual Counting tasks36-38 for visuoperceptual and visuospatial functions. 
Length and Size Discrimination. The stimuli consisted of 6 sets of lines, 3 sets of circles, 
and 3 sets of rectangles printed on separate sheets of A4-sized paper (total 12 sheets). 
Subjects were asked to point out the longest and shortest, the largest and smallest. The 
total score ranged from 0 to 20. 
Direction Discrimination. An examiner presented 15 pairs of lines printed on separate 
sheets of paper one by one. Five pairs were parallel to each other and 10 pairs were 
inclined at angles from 4 to 7 degrees. Subjects were asked to determine whether pairs of 
lines were parallel or not. Total score ranged from 0 to 15. 
Complex Form Discrimination. Four line-drawn geometric figures were placed in a 2 x 2 
array on each of 20 sheets of paper. Of each set of 4 figures, 3 were the same and 1 was 
slightly different, rotated or flipped. The subjects were instructed to point to the odd figure. 
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The maximum possible score was 20. 
Overlapping Figures. There were 3 sets of overlapping line drawings. Each set contained 3 
simple geometric figures, 4 man-made objects, and 5 fruits (a total of 12 objects). The 
subjects were asked to identify all individual figures, by naming, describing, tracing by 
finger, or matching them with non-overlapping drawings. The maximum possible score 
was 12. 
Visual Counting. The task consisted of 28 sheets of A4-sized paper, on each of which 
there were 4 to 12 simple figures (circles and triangles) of 1 or 2 colors (red and blue). 
Subjects were asked to count the number of figures with a specified color (red or blue) and 
form (circle or triangle), and the total number of figures. The maximum possible score was 
56. Details of the visuoperceptual and visuospatial tasks have been described 
elsewhere.36-38 
 
3-1-3. Statistical analyses 
  Group comparisons at baseline were made by using Kruskal-Wallis test (p = 0.05). 
Post-hoc pairwise comparisons between the iNPH and NC and between the iNPH and AD 
groups were tested using Mann-Whitney U test with Bonferroni correction (p = 0.025) 
Comparisons between baseline and post-shunt surgery were made by using Wilcoxon’s 
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signed rank test (p = 0.05). All statistical analyses were performed with R 2.9.0 (R 
Development Core Team 2008). 
 
3-2. Results 
3-2-1. Group comparisons of neuropsychological test performances at baseline 
The results are summarized in Table 3. There were significant differences among the 
three groups for all test scores (p < 0.05) except for the WAB Object Naming (p = 0.055), 
ADAS False Recall (p = 0.196), and Length and Size Discrimination (p = 1.000). Below 
are described in detail the results of pairwise comparisons on the tests, in which significant 
group-level differences were found. 
Although the iNPH group performed significantly worse than the NC group on the 
MMSE, there was no significant difference between the iNPH and AD groups. Compared 
to the NC group, the iNPH group performed significantly worse on the Digit Span and 
Category Fluency. There were no significant differences between the iNPH and AD groups 
on these tests. On the Spatial Span, Phoneme Fluency, TMT-A and FAB, the performance 
of the iNPH group was worse than the performances of the other two groups.  
Compared to the NC group, the iNPH group was impaired on True Recall, True 
Recognition, and d’ of the ADAS, whereas the iNPH and AD groups were comparable on 
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these measures. The iNPH patients made fewer false recognition responses than the AD 
patients. No significant differences were found between the iNPH and NC groups in terms 
of the number of false recognition responses.  
Although the performance of the iNPH group was significantly worse than that of the 
NC group on the Direction Discrimination and Overlapping Figure, there was no 
significant difference between the iNPH and AD groups. On the Complex Form 
Discrimination and Visual Counting, the performance of the iNPH group was significantly 
worse than those of the other two groups. 
 
3-2-2. Changes in neuropsychological test performances after shunt surgery 
The results are shown in Table 4. One year after CSF shunt surgery, performances of 
the TMT-A and FAB were significantly improved (p < 0.05). The other test performances 
were not significantly different before and after shunt surgery (p > 0.05). 
 
3-3. Discussion 
In line with previous studies,39-41 STUDY 1 demonstrated that iNPH patients were 
impaired in measures of executive functions. This finding is consistent with the 
characterization of the cognitive and behavioral disturbances of iNPH as ‘subcortical 
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dementia’, whose neuropsychological deficits involve executive or ‘frontal lobe’ 
dysfunction.42-44 Previous neuroimaging studies support the view that ‘frontal lobe’ 
dysfunction originates not from damage to the frontal cortex itself, but remote effects of 
subcortical lesions in iNPH; SPECT studies45-47 have demonstrated regional cerebral blood 
flow (rCBF) decrease in the lateral and medial frontal cortices, whereas there was no 
significant gray matter loss in these regions in a voxel-based morphometric (VBM) 
study.48 
It has been repeatedly claimed that the pattern of memory deficit in iNPH is of ‘frontal 
lobe’ type, in which recall is disproportionately affected relative to recognition 
memory.49-51 However, no previous studies have provided empirical evidence of relative 
preservation of recognition memory in iNPH. In this study, these two different aspects of 
memory were directly evaluated in iNPH and AD, and were affected comparably in the 
two disorders. The present results suggest that memory impairment in iNPH is not 
exclusively ascribable to frontal lobe dysfunction. Episodic memory is a function 
subserved by a network consisting of several neuroanatomical regions, including the 
medial temporal lobe, thalamus, retrosplenial cortex, and white-matter structures 
containing fibers interconnecting these brain regions. A recent neuroimaging study 
demonstrated medial temporal volume reduction in iNPH.48 Damage to the hippocampus 
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and the adjacent medial temporal structures are major candidates for the memory deficit in 
iNPH. Increased false recognitions have been reported to be one of the characteristic 
features of recognition memory in AD.52 Some investigators have stressed the contribution 
of executive dysfunction to the emergence of false recognitions.53 However, a lower rate of 
false recognitions in iNPH cannot be explained by this hypothesis, because executive 
function was more defective in iNPH than in AD. Previous studies showed that patients 
with depressive pseudo-dementia54 and with progressive supranuclear palsy55 made fewer 
false recognition errors than those with AD. Severer apathy or less productivity in iNPH 
and other subcortical dementias20 than in AD might explain conservative response bias and 
a lower rate of false recognitions. 
Visuoperceptual and visuospatial functions have not been addressed in previous studies 
of iNPH. The present investigation demonstrated significant impairment of these functions 
in this disorder. Defective performance on the visual discrimination tasks suggests that 
patients with iNPH are impaired in visual form perception or constructive function.36-38 
This result is consistent with those of a previous study showing impaired performance of 
iNPH patients on the Block Design task.40 The patients with iNPH are impaired also on the 
Visual Counting task.36-38, 56 Although this task requires working memory, the primary 
contribution of the parietal cortex is suggested by the previous observation,57 in which 
21 
 
patients with frontal lobe damage performed normally on this task. We should consider the 
roles of the extensive subcortical white matter lesions in parietal lobe dysfunction.46 
The longitudinal part of STUDY 1 revealed that CSF shunt surgery improved 
executive function that was impaired at baseline. Previous studies demonstrated that the 
FAB had good a good test-retest reliability in patients with dementia73, 74, and that the 
TMT-A had no practice effect in patients with NPH75. Therefore, a practice effect is 
unlikely, and the improvement demonstrated on these tests are attributable not to practice 
but to the shunt effect. These results are consistent with those of previous neuroimaging 
studies that showed improvement of the frontal and parietal CBF after shunt surgery.17, 18 
Improvement of visuoperceptual and visuospatial functions did not reach statistical 
significance in this study. The negative result may come from the small sample size in the 
present study. 
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4. STUDY 2. Neuropsychiatric profile of iNPH 
4-1. Methods 
4-1-1. Subjects 
Inclusion criteria for the patients were the same as those of STUDY 1. Written 
informed consent was obtained from all the participants. Forty-five patients (20 women, 25 
men) with definite iNPH on the JSNPH criteria6 (Table 1) were recruited from consecutive 
iNPH patients who underwent detailed evaluation in the two hospitals described above 
from January 2005 to February 2009. The definition of significant clinical improvement 
was same as in STUDY 1. The subjects’ mean (SD) age, duration of education, and 
MMSE scores were 76.2 (4.2) years (range 65-84), 10.2 (3.5) years, and 20.9 (4.7), 
respectively. The mean (SD) iNPHGS scores before and after CSF shunt operation were 
2.5 (0.7) and 2.0 (1.0) (Wilcoxon test; Z = -3.213, p = 0.001) for cognitive, 2.3 (0.6) and 
1.5 (0.9) (Z = -4.021, p < 0.001) for gait, 1.8 (1.0) and 0.9 (1.1) (Z = -3.531, p < 0.001) for 
urinary, and 6.7 (1.8) and 4.3 (2.3) (Z = -4.400, p < 0.001) for total score, respectively. 
Thirty-two patients received VP shunt surgery and 13 patients received LP shunt surgery. 
The mean (SD) interval between interview and surgery was 69.4 (41.2) days. For 
longitudinal part of STUDY 2, patients who could not follow up for clinical reasons such 
as death, institutionalization, and complications after surgery were excluded, and thus 
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postoperative evaluation was carried out in 29 patients approximately one year after shunt 
surgery. The mean (SD) duration of the follow-up was 12.6 (1.1) months (range 11-15 
months). The mean (SD) age of the patients was 75.6 (4.0) years (range 67–84 years), and 
their mean duration of education was 10.0 (3.2) years. The neuro-psychopharmacological 
treatment was unchanged in most of the patients from baseline to 1-year after surgery 
except for 4 patients: trazodone 25mg/day was substituted by paroxetine 40 mg/day (n = 1) 
or by donepezil 5mg/day (n = 1); amantadine 50mg/day and paroxetine 20 mg/day were 
discontinued (n = 1); risperidone 0.3mg/day were started (n =1). 
As a disease control group, 45 patients with AD (26 women, 19 men) matched for age, 
sex, duration of education, and degree of cognitive dysfunction represented by the MMSE 
were selected from the same pools of patients described above. The means (SD) of age, 
duration of education, and MMSE score were 76.0 (4.5) years (range 64–87 years), 10.3 
(2.6) years, and 21.9 (3.8), respectively. I found no significant differences between the 
iNPH and AD groups in terms of age (t = 0.289, p = 0.773), sex (Pearson’s χ2 test, χ = 
1.601, p = 0.206), duration of education (t = -0.205, p = 0.838), and MMSE score (t = 
-1.090, p = 0.279) (Table 5). 
 
4-1-2. Clinical and neuropsychiatric assessments 
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A modified version of NPI58 was used for the assessment of neuropsychiatric 
symptoms. The NPI is a caregiver-based behavioral rating system validated for the 
assessment of mental state and behavioral abnormalities in dementia. In the original NPI,59 
the 10 neuropsychiatric symptoms (delusions, hallucinations, agitation/aggression, 
depression/dysphoria, anxiety, euphoria, apathy, disinhibition, irritability/lability, and 
aberrant motor behavior) of dementia were rated in terms of frequency (range 1-4) and 
severity (1-3) on the basis of the patient’s condition in the month preceding the interview. 
A frequency rating multiplied by a severity rating produces a subscale score for each 
behavior, and the summation of subscale scores produces the total NPI score.60 In this 
study, the modifications included a distinction of ‘delusion’ between two different 
categories – persecution delusion and delusional misidentification – and an addition of a 
domain for fluctuation of cognition.58, 61 Therefore, the modified NPI consisted of 12 
domains, and the maximum total score was different from that of the original version (120 
in the original and 144 in our modified version).  
Locomotor function was assessed only in iNPH patients using the 3-Meter Timed Up 
& Go (TUG) test.62 TUG is a valid test of functional mobility used in many studies to 
evaluate locomotor function. The TUG measures the time to take to stand up from sitting 
in an armchair, walk forward 3 meters, and return to the seated position. No physical 
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assistance is given. In the present study, if a patient was at risk of falling, the examiner 
followed a half-step behind the patient as a precaution in case of falling, but without 
affecting the patient’s walking pace. 
 
4-1-3. Statistical analyses 
Group comparisons of NPI at baseline were made using the χ2 test for analysis of 
prevalence, and the Mann-Whitney U test for analysis of scoring data (p = 0.05). 
Correlation analysis was made with Spearman’s correlation coefficients (p = 0.05). 
Comparisons between baseline and post-shunt surgery were made by using McNemar test 
(for prevalence) and Wilcoxon’s Signed Rank test (for scoring data) (p = 0.05). All 
statistical analyses were performed with the R 2.9.0 (R Development Core Team 2008). 
 
4-2. Results 
4-2-1. Group comparisons of neuropsychiatric profiles at baseline 
The results of NPI at baseline are summarized in Table 6. In the iNPH group, apathy 
was the most frequently occurring symptom (80.0%), followed by agitation (48.9%) and 
irritability (42.2%). I found that apathy and irritability were significantly more common in 
the iNPH group than in the AD group (p < 0.05) (Table 6). Prevalence of the other 
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symptoms was not significantly different between the two groups. The iNPH group had 
significantly higher scores than the AD group for agitation/aggression, apathy, 
irritability/lability, and fluctuation of cognition (Table 6). Scores of the remaining domains 
were not significantly different between the two groups. 
 
4-2-2. Correlations between neuropsychiatric symptoms and motor or cognitive 
abilities in the iNPH group 
Four patients could not complete TUG within 60 sec. The mean (SD) time required for 
completing TUG by patients in the iNPH group was 18.2 (9.3) sec. The results of 
correlation analyses between the neuropsychiatric symptoms and cognitive or locomotor 
dysfunctions in iNPH are shown in Table 7. There were no significant correlations 
between the scores for neuropsychiatric symptoms and the TUG. I found significant 
negative correlation between apathy and MMSE score (Spearman’s r.s. = -0.303, p = 
0.043), and trends of correlation between agitation score and MMSE score (Spearman’s r.s. 
= 0.267, p = 0.076), aberrant motor behavior score and MMSE score (Spearman’s r.s. = 
-0.273, p = 0.069), and fluctuation of cognition and MMSE score (Spearman’s r.s. = 
-0.246, p = 0.080). There was no significant correlation between irritability and MMSE 
score (Spearman’s r.s. = 0.005, p = 0.973). There were highly significant correlations 
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between hallucination score and aberrant motor behavior score (Spearman’s r.s. = 0.699, p 
< 0.001), agitation score and irritability score (Spearman’s r.s. = 0.411, p = 0.005), anxiety 
score and irritability score (Spearman’s r.s. = 0.421, p = 0.004), and dysphoria score and 
anxiety score (Spearman’s r.s. = 0.626, p < 0.001). 
 
4-2-3. Changes in neuropsychiatric profiles after shunt surgery 
The mean (SD) MMSE score was significantly improved 1 year after CSF shunt 
surgery (from 22.1 (4.3) to 23.4 (4.5); Wilcoxon test; Z = -3.260, p < 0.05). The changes in 
scores on the modified NPI 1 year after CSF shunt surgery are shown in Table 7. The 
prevalence of agitation/aggression was significantly reduced compared to baseline (p < 
0.05) (Table 8). The prevalence of the other symptoms was not significantly different 
before and after surgery (p > 0.05). The scores of agitation/aggression and fluctuation of 
cognition were significantly reduced after surgery. Scores of the remaining domains were 
not significantly different before and after surgery (p > 0.05). 
 
4-2-4. Subgroup analysis for changes in MMSE and NPI-agitation scores after shunt 
surgery 
A subgroup analysis was carried out to further explore the relationship between the 
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changes of MMSE and NPI-agitation scores. The iNPH patients were divided into two 
subgroups according to severity of cognitive impairment, group of patients with minimal 
cognitive impairment (MMSE≧23; 5 women, 9 men; mean (SD) age: 75.4 (4.8) years; 
mean (SD) years of education: 11.6 (3.1) years), and group of patients with more severe 
cognitive impairment (MMSE<23; 7 women, 8 men; mean (SD) age: 75.7 (3.5) years; 
mean (SD) years of education: 8.9 (3.0) years). The minimally impaired group did not 
improve for MMSE score (from 25.1 (2.2) to 25.4 (3.5); Wilcoxon test; Z = -0.158, p = 
0.875), but for NPI-agitation score (from 2.0 (2.3) to 0.3 (1.1); Z = -2.442, p = 0.015) 
(Figure 1). In the severely impaired group, the mean MMSE score was improved (from 
19.2 (3.8) to 21.6 (4.7); Z = -2.215, p = 0.027), although NPI-agitation score was not 
significantly changed (from 0.9 (1.4) to 0.5 (1.0); Z = -0.816, p = 0.414) (Figure 1). 
 
4-3. Discussion 
In STUDY 2, the features of neuropsychiatric symptom in iNPH were elucidated. The 
results can be summarized as follows; (i) Apathy, agitation, and irritability were common 
neuropsychiatric symptoms; (ii) In a comparison with AD, iNPH was characterized by 
higher prevalence and greater severity of apathy, and greater severity of agitation, 
irritability, and fluctuation of cognition; (iii) These neuropsychiatric symptoms were 
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linked to cognitive dysfunction but not to motor impairment; severity of apathy paralleled 
that of cognitive dysfunction, whereas agitation tends to dominate in patients with 
relatively mild cognitive dysfunction: and (iv) Shunt surgery improved agitation and 
fluctuation of cognition but not apathy. 
Apathy is defined as loss of drive/motivation, or lack of feeling/emotion. This 
symptom is commonly observed in various cerebral diseases. For example, apathy has 
been reported to be one of the most common behavioral symptoms in AD, frontotemporal 
lobar degeneration, dementia in Parkinson’s disease, and vascular dementia. Compared to 
previous reports of these disorders, however, the prevalence of apathy is exceptionally 
high in iNPH. As was found in the present study, previous studies have reported the 
presence of apathy in more than 80% of patients with iNPH.19, 20 There is a possibility that 
concomitant motor deficits lead to an overestimation of the incidence of apathy. However, 
the significant correlation of apathy with cognitive dysfunction but not with gait 
disturbance negates this possibility. Previous neuroimaging studies of AD, cerebral 
infarction, and iNPH suggest that apathy is associated with dysfunction of the anterior 
cingulate cortex.63-66 A SPECT study has indicated that rCBF in the anterior cingulate 
cortex is more severely decreased in iNPH than in AD,16 a finding that may be explained 
by the higher prevalence and greater severity of this symptom in iNPH.  
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The scores of agitation and irritability were highly correlated with each other, 
suggesting that these symptoms share underlying mechanisms in iNPH. The close 
relationship between agitation and irritability was also demonstrated in AD and vascular 
dementia.67 Irritability and agitation are often described in relation to frontal lobe damage. 
In particular, these behavioral symptoms emerge as a manifestation of disinhibition and 
antisocial behaviors in those with orbitofrontal injury.68 In AD and traumatic brain injury, 
agitation is reportedly prevalent and severe in patients with frontotemporal involvement.69, 
70 In contrast, a VBM study71 failed to find any neural correlates of agitation and 
irritability in frontotemporal lobar degeneration. The lack of consistency of neuronal 
correlates across the diseases suggests that mechanisms underlying agitation and 
irritability are multifaceted. However, a trend of negative correlation between cognitive 
dysfunction and agitation suggests that relative preservation of cognition is a contributing 
factor to the development of this symptom. Although disruption of the frontal-subcortical 
circuits due to white matter pathology may be associated with the development of agitation 
and irritability, additional factors should be considered to explain the high prevalence of 
these symptoms in iNPH.  
There are many common symptomatic features between iNPH and confusional 
state/delirium: poor attention, psychomotor retardation, fluctuation of symptoms, loss of 
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spontaneity, and agitation/irritability. Some investigators pointed out impaired arousal and 
wakefulness in iNPH and their similarity to consciousness disturbance.20 Arousal is a 
function of ascending activating projections to the cerebral cortex that arise from the upper 
brainstem, thalamus, and basal forebrain.68, 72 In NPH, compression or congestion in the 
white matter structures due to excessive retention of CSF in the cranial cavity may be 
associated with confusion/delirium-like behavioral changes such as agitation, apathy, and 
fluctuation of cognition. This view predicts global improvement of brain function as a 
result of CSF shunt surgery. This prediction is in line with previous neuroimaging studies 
showing extensive increase of rCBF in the frontal, parietal, and subcortical regions after 
shunt surgery.17, 18  
Improvement of agitation and cognitive fluctuation after CSF shunt treatment are also 
reminiscent of the processes of recovery from delirium/confusional state. However, the 
lack of improvement in apathy in the present study is incompatible with such a ‘global 
hypothesis’. Lindqvist and colleagues20 found that shunt surgery improves arousal deficit 
only in patients with somnolence-sopor-coma disorder, the most severe forms of 
consciousness disturbance in iNPH. Mild to moderate disturbance of arousal and 
spontaneity, which is observed in the majority of the present patient population, may be 
less responsive to shunt treatment.19, 20 
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MMSE score and severity of agitation were positively correlated with each other at 
baseline. Both the MMSE score was increased and agitation was improved after CSF shunt 
surgery. A Subgroup analysis revealed that the group of minimal cognitive impairment did 
not improve for the MMSE but for agitation score. In contrast, the group of severe 
cognitive impairment improved for the MMSE score, but not for agitation score. These 
results suggest that the improvement of neuropsychiatric symptom is not in parallel with 
cognitive improvement. Applying a shunt surgery to a patient with relatively mild 
cognitive impairment benefits neuropsychiatric symptoms rather than cognitive 
impairment. 
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5. GENERAL DISCUSSION 
The cognitive and behavioral/neuropsychiatric characteristics of iNPH have been 
classified into a category of ‘subcortical dementia’ as like vascular dementia, progressive 
supranuclear palsy, Parkinson’s disease with dementia, and so on. Although such a 
labeling adequately captures some aspects of the clinical features of these disorders, it does 
not provide enough of the information that is required in clinical settings. Deeper 
understanding of the symptoms is necessary for establishment of accurate diagnosis and 
appropriate therapeutic indication. For example, recent progress in understanding the 
cognitive and behavioral symptoms of Parkinson’s disease, which has classically been 
considered to be a pure motor disease, has provided the foundation for new therapeutic 
strategies such as cholinesterase inhibitors. In contrast, there have been few systematic 
investigations of the clinical features of iNPH to date, which is why I conducted the two 
investigations described here. 
The present studies delineate the core and diverse cognitive and behavioral features of 
iNPH. STUDY 1 demonstrated that patients with iNPH were impaired in broader cognitive 
domains than previously believed. Their deficits extend beyond executive function and 
memory into visuoperceptual/visuospatial functions. STUDY 2 revealed that patients with 
iNPH present with various neuropsychiatric symptoms. Although negative symptoms such 
34 
 
as apathy and decreased arousal have previously been emphasized as neuropsychiatric 
features of iNPH, a high prevalence of positive symptoms, such as agitation and irritability, 
was noted.  
Another important issue addressed in the present studies was which symptoms can be 
relieved by CSF shunt surgery. Although the beneficial effects of CSF shunt surgery on 
gait ability have been well documented, it remains unclear which aspects of cognitive and 
behavioral symptoms are likely to respond to CSF shunt surgery. As for cognitive 
symptoms, significant improvement was observed only in executive function, not in 
visuoperceptual/visuospatial functions. Among the various neuropsychiatric symptoms, 
only agitation and cognitive fluctuation were responsive to CSF shunt surgery. 
The MMSE was not significantly improved after shunt surgery in STUDY 1, but was 
improved in STUDY 2. This disagreement would be attributed to the small sample size 
and hence lower statistical power. The number of patients included in STUDY 1 
longitudinal part (n = 23) was smaller than that in STUDY 2 (n = 29), because the patients 
who could not complete a full of neuropsychological examinations were excluded. 
Although a selection bias might characterize the subjects, little difference exists between 
the two studies on the mean (SD) MMSE score before (STUDY 1: 22.0 (4.7); STUDY 2: 
22.1 (4.3)) and after shunt surgery (STUDY 1: 23.1 (4.7); STUDY 2: 23.4 (4.5)).  
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While iNPH is one of a group of prototypic disorders of ‘subcortical dementia’, AD 
patients were selected as a disease control group because AD is the most common and 
important cause of dementia. In terms of clinical implications, it is important to clarify the 
differences from AD patients for cognitive dysfunction and neuropsychiatric symptoms. 
For example, the cognitive dysfunction in AD patients, which is characterized as amnesia 
and posterior cortical dysfunctions, are now widely known, whereas they were not fully 
investigated in iNPH. The fact that posterior cortical dysfunction in iNPH was more severe 
than in AD suggests that it could be useful index in the differential diagnosis in clinical 
situations. However, it is also necessary to differentiate other subcortical dementias, such 
as progressive supranuclear palsy or subcortical ischemic vascular dementia, where both 
similar parkinsonian gait disturbance and frontal-type cognitive dysfunction emerge. 
Although it would be more difficult to distinguish from these disorders, distinctive features 
should be delineated in future studies. 
On the basis of the present findings, two issues are to be pursued in future study. The 
first issue concerns the relationship between cognitive and neuropsychiatric symptoms and 
patients’ quality of life as well as the burden placed on their caregivers. Previous studies of 
dementia have indicated that positive symptoms such as agitation are the main cause of 
distress for caregivers and that euphoria is less of a problem.76 The effect of CSF shunt 
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surgery on quality of life and on the burden for caregivers should be clarified. The next 
issue is related to the neural (lesional) correlates of symptoms. Brain-behavior correlation 
analyses using quantitative neuroimaging techniques such as VBM and diffusion tensor 
imaging will be useful. I believe that these investigations will provide fundamental 
evidence of the pathophysiology of iNPH. 
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8. FIGURE 
Figure 1. The mean scores of the MMSE and NPI-Agitation before and after surgery for 
the subgroups of mild and moderate cognitive impairments at baseline. 
p values are based on Wilcoxon test.  
MMSE: Mini Mental State Examination, NPI: Neuropsychiatric Inventory. 
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9. TABLES 
Table 1. Diagnostic criteria of iNPH6 
Diagnostic criteria Supplementary notes 
Possible iNPH  
1. Individuals who develop symptoms in their 60s or older. 1. Small stride, shuffle, instability in walking and increase of 
instability on turning. 
2. More than one of the clinical triad: gait disturbance, cognitive 
impairment, and urinary incontinence. 
2. Symptoms are slowly progressive; however, sometimes an 
undulating course, including temporal discontinuation of 
development and exacerbation, is observed. 
3. Ventricular dilation (Evans Index > 0.3)*. 3. Other neurological diseases, including Parkinson’s disease, 
Alzheimer’s disease, and cerebrovascular diseases, may coexist; 
however, all such diseases should be mild. 
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4. CSF pressure of 200 mmH2O or less and normal CSF content. 4. Narrowing of sulci and subarachnoid spaces over the high 
convexity and midline surface, and dilation of the sylvian fissure 
and basal cistern are often observed. 
5. The above-mentioned clinical symptoms cannot be completely 
explained by other neurological or non-neurological diseases. 
5. Periventricular lucency or periventricular hyperintensity is not 
essential. 
6. Preceding diseases possibly causing ventricular dilation are not 
obvious, including subarachnoid hemorrhage, meningitis, head 
injury, congenital hydrocephalus, and aqueductal stenosis. 
6. Measurement of CBF is useful for differentiation from other 
dementias. 
  
Probable iNPH  
1. Meet requirements for possible iNPH.  
2. Meet one of the following;  
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a) Improvement of symptoms after CSF tap test. 
b) Improvement of symptoms after CSF drainage test. 
c) Abnormality in Ro measurement and ICP monitoring. 
  
Definite iNPH  
1. Improvement of symptoms after shunt surgery.  
*Evans Index: the ratio of the maximum width of the frontal horns to the maximum width of the inner table of the cranium. CBF: 
cerebral blood flow, ICP intracranial pressure, Ro: cerebrospinal fluid outflow resistance.
Table 2. Demographic and clinical profiles of the iNPH, AD, and NC groups in STUDY 1. 
p values are based on χ2 test# and one-way ANOVA*. 
 iNPH AD NC p value 
n (female/male) 34 (16/18) 34 (20/14) 30 (15/15) 0.602# 
Age (SD) in years 76.2 (4.6) 76.7 (4.9) 76.8 (5.7) 0.872* 
Years of education (SD)  10.2 (3.5) 9.5 (2.3) 10.5 (2.8) 0.416* 
CSF shunt operation (VP/LP) 23/11 - -  
SD: standard deviation, CSF: cerebrospinal fluid, VP: ventriculo-peritoneal, LP: 
lumbo-peritoneal. 
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Table 3.  The mean (SD) neuropsychological test scores of the iNPH, AD, and NC groups. 
Test/subtest  iNPH (/34) AD (/34) NC (/30) χ2(2) p value Pairwise 
comparisons 
MMSE /30 21.6 (4.5) 21.0 (3.3) 28.7 (1.3) 55.585 < 0.001 NC > iNPH† 
Digit Span  7.7 (1.8) 8.4 (1.4) 9.4 (1.6) 14.309 0.001 NC > iNPH† 
Spatial Span  7.6 (1.9) 8.6 (1.4) 10.6 (1.8) 33.294 < 0.001 NC, AD > iNPH 
Word Fluency        
  Phoneme  11.5 (6.2) 16.3 (7.5) 22.1 (7.8) 27.277 < 0.001 NC, AD > iNPH 
  Category  7.4 (4.2) 8.0 (3.0) 15.1 (5.3) 39.229 < 0.001 NC > iNPH† 
TMT-A Sec 158.6 (109.1) 97.6 (62.8) 52.3 (19.5) 33.652 < 0.001 iNPH > NC, AD 
FAB /18 9.9 (2.9) 11.9 (2.5) 15.7 (1.7) 50.342 < 0.001 NC, AD > iNPH 
WAB Object Naming /60 57.9 (3.2) 57.0 (3.5) 58.7 (1.6) 5.783 0.055  
ADAS        
True Recall /30 13.1 (4.3) 13.9 (3.9) 21.5 (2.8) 48.848 < 0.001 NC > iNPH† 
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SD: standard deviation, MMSE: the Mini-Mental State Examination, TMT-A: Trail Making Test-A, FAB: the Frontal Assessment 
Battery, WAB: the Western Aphasia Battery, ADAS: the Alzheimer’s Disease Assessment Scale. 
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Values are means (SD) with p values based on the Kruskal-Wallis and the post hoc Mann-Whitney test with Bonferroni correction. 
False Recall  0.6 (0.9) 0.9 (1.6) 0.3 (0.5) 3.263 0.196  
True Recognition /36 24.1 (9.4) 25.4 (10.5) 31.3 (3.9) 11.701 0.003 NC > iNPH† 
False Recognition /36 0.7 (2.3) 4.0 (6.3) 0.1 (0.3) 29.394 < 0.001 AD > iNPH† 
 d’  2.60 (0.96) 2.17 (0.95) 3.37 (0.52) 27.211 < 0.001 NC > iNPH† 
Visual Discrimination        
Length and Size /20 20.0 (0.0) 20.0 (0.0) 20.0 (0.0) 0.000 1.000  
Direction /15 13.9 (2.2) 13.6 (1.7) 15.8 (0.5) 14.564 0.001 NC > iNPH† 
Complex Form /20 18.3 (2.4) 19.6 (0.7) 19.7 (0.6) 14.856 0.001 NC, AD > iNPH 
Overlapping Figures /12 11.9 (2.1) 11.7 (0.6) 12.0 (0.2) 7.055 0.029 NC > iNPH† 
Visual Counting /56 50.0 (5.2) 53.8 (2.7) 55.2 (1.0) 33.237 < 0.001 NC, AD > iNPH 
†Other comparisons were not significant. 
 
Table 4.  The mean (SD) neuropsychological test scores before and after shunt surgery. 
Test/subtest  Pre (n=23) Post (n=23) Z value p value 
MMSE /30 22.0 (4.7) 23.1 (4.7) -1.621 0.105 
Digit Span  7.7 (2.0) 7.8 (1.7) -0.681 0.496 
Spatial Span  7.7 (2.0) 7.8 (1.6) -0.209 0.834 
Word Fluency      
  Phoneme  11.6 (5.7) 11.9 (6.4) -0.718 0.473 
  Category  7.6 (3.1) 7.6 (4.0) -0.131 0.895 
TMT-A Sec 173.4 (123.0) 129.4 (86.3) -2.403 0.016 
FAB /18 10.1 (3.0) 11.4 (3.6) -2.401 0.016 
WAB Object Naming /60 58.3 (3.3) 58.9 (2.5) -1.318 0.187 
ADAS      
True Recall /30 13.4 (4.2) 13.7 (5.3) -0.458 0.647 
False Recall  0.5 (0.9) 0.4 (0.8) -0.318 0.751 
True Recognition /36 23.5 (8.5) 22.6 (10.0) -0.455 0.649 
False Recognition /36 0.8 (2.7) 0.1 (0.5) -1.289 0.197 
 d’  2.51 (0.84) 2.50 (0.97) 0.000 1.000 
Visual Discrimination      
Length and Size /20 20.0 (0.0) 20.0 (0.0) 0.000 1.000 
Direction /15 13.5 (1.5) 13.3 (1.7) -0.676 0.499 
Complex Form /20 18.1 (2.3) 18.7 (1.5) -1.377 0.169 
Overlapping Figures /12 11.5 (0.8) 11.6 (0.9) -0.776 0.438 
Visual Counting /56 50.3 (5.6) 52.2 (3.9) -1.637 0.102 
SD: standard deviation, MMSE: the Mini-Mental State Examination, TMT-A: Trail 
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Making Test-A, FAB: the Frontal Assessment Battery, WAB: the Western Aphasia 
Battery, ADAS: the Alzheimer’s Disease Assessment Scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
Table 5. Demographic and clinical profiles of the iNPH and AD groups in STUDY 2. 
p values are based on the χ2 test# and t test*. 
 iNPH AD p value 
n (female/male) 45 (20/25) 45 (26/19) 0.206# 
Age (SD) in years 76.2 (4.2) 76.0 (4.5) 0.773* 
Years of education (SD) 10.2 (3.5) 10.3 (2.6) 0.838* 
MMSE 20.9 (4.7) 21.9 (3.8) 0.279* 
CSF shunt operation (VP/LP) 32/13 -  
SD: standard deviation, CSF: cerebrospinal fluid, VP: ventriculo-peritoneal, LP: 
lumbo-peritoneal. 
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Table 6.  The prevalence and mean scores of NPI symptoms in the iNPH and AD groups. 
 Prevalence  Mean (SD) score 
Question items iNPH (/45) AD (/45) χ2 p value  iNPH (/45) AD (/45) Z value p value
Persecution delusion 20.0% 28.9% 0.963 0.327  0.56 (1.91) 1.18 (2.52) -1.210 0.226 
Delusional misidentification 6.7% 4.4% 0.212 0.645  0.07 (0.25) 0.04 (0.21) -0.458 0.647 
Hallucination 6.7% 2.2% 1.047 0.306  0.16 (0.64) 0.02 (0.15) -1.040 0.299 
Agitation/aggression 48.9% 28.9% 3.787 0.052  1.53 (2.40) 0.42 (0.81) -2.504 0.012 
 Dysphoria/depression 31.1% 35.6% 0.200 0.655  0.62 (1.11) 0.64 (1.11) -0.329 0.742 
Anxiety 26.7% 33.3% 0.476 0.490  0.67 (1.33) 0.71 (1.25) -0.559 0.576 
Euphoria 0.0% 4.4% 2.045 0.153  0.00 (0.00) 0.18 (0.94) -1.422 0.155 
Apathy 80.0% 48.9% 9.504 0.002  4.00 (3.20) 1.93 (2.44) -3.301 0.001 
 Disinhibition 11.1% 13.3% 0.104 0.748  0.22 (0.93) 0.40 (1.32) -0.376 0.707 
 Irritability/lability 42.2% 17.8% 6.402 0.011  1.04 (1.69) 0.87 (2.44) -2.153 0.031 
 Aberrant motor behavior 13.3% 15.6% 0.090 0.764  0.64 (1.90) 0.53 (1.50) -0.178 0.859 
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Values are means (SD) with p values based on the χ2 test or t test. 
 Fluctuation of cognition 37.8% 20.0% 3.462 0.063  1.00 (1.57) 0.42 (0.97) -1.974 0.048 
Total 91.1% 88.9% 0.123 0.725  10.51 (7.99) 7.31 (6.65) -2.005 0.045 
SD: standard deviation. 
 
 
 
 
 
Table 7.  Correlations between neuropsychiatric symptoms and motor or cognitive abilities in iNPH. 
  TUG MMSE Persecution Misidentification Hallucination Agitation Dysphoria Anxiety Euphoria Apathy Disinhibition Irritability Aberrant motor Fluctuation of cognition 
TUG Correlation coefficient 1.000              
 p value (2-tailed) -              
MMSE Correlation coefficient -0.324 1.000             
 p value (2-tailed) 0.030 -             
Persecution delusion Correlation coefficient -0.061 -0.188 1.000            
 p value (2-tailed) 0.692 0.217 -            
Delusional misidentification Correlation coefficient 0.124 -0.230 0.074 1.000           
 p value (2-tailed) 0.419 0.128 0.630 -           
Hallucination Correlation coefficient 0.144 -0.232 0.114 0.293 1.000          
 p value (2-tailed) 0.347 0.126 0.458 0.050 -          
Agitation/aggression Correlation coefficient -0.014 0.267 -0.260 0.041 -0.066 1.000         
 p value (2-tailed) 0.926 0.076 0.084 0.791 0.665 -         
Dysphoria/depression Correlation coefficient 0.079 -0.101 0.057 0.201 0.047 0.330 1.000        
 p value (2-tailed) 0.604 0.509 0.708 0.185 0.760 0.027 -        
Anxiety Correlation coefficient 0.165 0.005 0.048 0.071 0.013 0.326 0.626 1.000       
 p value (2-tailed) 0.278 0.975 0.756 0.645 0.935 0.029 <0.001 -       
Euphoria Correlation coefficient - - - - - - - - -      
 p value (2-tailed) - - - - - - - - -      
Apathy Correlation coefficient -0.028 -0.303 0.060 0.046 -0.027 0.182 0.223 0.199 - 1.000     
 p value (2-tailed) 0.853 0.043 0.694 0.763 0.861 0.231 0.140 0.190 - -     
Disinhibition Correlation coefficient -0.080 -0.039 0.210 -0.094 -0.094 0.267 0.183 0.228 - -0.097 1.000    
 p value (2-tailed) 0.600 0.801 0.167 0.537 0.538 0.076 0.228 0.132 - 0.527 -    
Irritability/lability Correlation coefficient -0.110 0.005 0.183 -0.046 -0.042 0.411 0.153 0.421 - 0.228 0.240 1.000   
 p value (2-tailed) 0.472 0.973 0.228 0.764 0.783 0.005 0.316 0.004 - 0.132 0.113 -   
Aberrant motor behavior Correlation coefficient 0.026 -0.273 0.364 0.180 0.699 -0.034 0.072 0.046 - 0.076 0.082 0.210 1.000  
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 p value (2-tailed) 0.867 0.069 0.014 0.237 <0.001 0.827 0.638 0.762 - 0.618 0.590 0.166 -  
Fluctuation of cognition Correlation coefficient 0.135 -0.264 -0.083 -0.071 0.056 -0.029 0.067 0.107 - 0.237 0.077 -0.064 0.052 1.000 
 p value (2-tailed) 0.378 0.080 0.587 0.643 0.714 0.851 0.661 0.486 - 0.117 0.617 0.676 0.734 - 
TUG: the 3-Meter Timed Up & Go test, MMSE: the Mini-Mental State Examination. 
 
Table 8.  The prevalence and mean scores of NPI symptoms pre and post shunt surgery. 
Question items Pre (/29) Post (/29) p value Pre (/29) Post (/29) Z value p value
Persecution delusion 13.8% 6.9% 0.625 0.52 (2.23) 0.31 (1.49) -1.414 0.157 
Delusional misidentification 0.0% 3.4% - 0.00 (0.00) 0.03 (0.19) -1.000 0.317 
Hallucination 3.4% 0.0% - 0.03 (0.19) 0.00 (0.00) -1.000 0.317 
Agitation/aggression 51.7% 17.2% 0.006 1.41 (1.94) 0.41 (1.02) -2.405 0.016 
 Dysphoria/depression 31.0% 17.2% 0.289 0.52 (0.99) 0.28 (0.65) -1.165 0.244 
Anxiety 20.7% 17.2% 1.000 0.55 (1.27) 0.48 (1.18) -0.318 0.750 
Euphoria 0.0% 0.0% - 0.00 (0.00) 0.00 (0.00) 0.000 1.000 
Apathy 75.9% 65.5% 0.508 3.48 (2.65) 3.31 (3.48) -0.352 0.725 
 Disinhibition 10.3% 13.8% 1.000 0.27 (1.13) 0.17 (0.47) -0.378 0.705 
 Irritability/lability 37.9% 27.6% 0.453 0.72 (1.16) 0.41 (0.87) -1.196 0.232 
 Aberrant motor behavior 6.9% 6.9% 1.000 0.17 (0.76) 0.07 (0.26) -0.378 0.705 
 Fluctuation of cognition 31.0% 10.3% 0.109 0.90 (1.61) 0.17 (0.60) -2.509 0.012 
Total 86.2% 75.9% 0.250 8.66 (6.83) 5.72 (5.64) -2.559 0.010 
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